Dr. Greg S. Morganroth, MD

Dr. Morganroth practices at Santa Clara Co IPA in Campbell, California.

Dr. Morganroth's NPI, 1639217458, was assigned on February 2, 2007. Dr. Morganroth graduated from University Of Michigan Medical School in 1990. Dr. Morganroth holds California license G81771.

Dr. Morganroth's primary practice is Santa Clara Co IPA, at 1580 S Winchester Blvd, Campbell, CA 95008 in Santa Clara County. The practice phone is (650) 358-5834.

Dr. Morganroth's primary practice is Santa Clara Co IPA in Campbell, California. The medical group on file is Schweiger Dermatology Group, San Pedro. Dmand AI also links Dr. Morganroth to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Morganroth practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Morganroth's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Morganroth is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Morganroth's licenses on file in 3 states: California, Connecticut and Pennsylvania.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, itchy rashes, minor injury to a limb and scalp rash among the conditions Dr. Morganroth treats.

CMS data shows 6,903 Medicare services from Dr. Morganroth across 34 procedure codes in 2024, for 1,002 Medicare patients. Medicare paid $1,495,047 for them.

CMS counts 1,002 Medicare patients who saw Dr. Morganroth in 2024. The largest group is 75 to 84, with 428 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Morganroth's median patient age at 68, with 52% women.

In 2024, Dr. Morganroth wrote 743 Medicare Part D claims for 534 patients. 100% of them were for generic drugs. CMS names the drug for 686 of them, across 4 drugs with 11 or more claims each, at $5,892 in total drug cost. In 2023, CMS named 607 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Morganroth for performance year 2024, reported as part of a group. Dr. Morganroth accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 762 procedures of melanoma (skin cancer) excision by Dr. Morganroth, more than 99% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Morganroth in 2006. The most frequent topics are Skin, Skin Neoplasms and Aging. Dr. Morganroth has published most often in J Am Acad Dermatol. Dr. Morganroth's most frequent co-authors are Jean L. Bolognia, MD, Joel Lee Cohen, MD and Hayes Bordman Gladstone, MD.

CMS Open Payments shows 261 general payments to Dr. Morganroth from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $1,584.

Dmand AI lists 2 awards for Dr. Morganroth.

Dr. Morganroth graduated from University Of Michigan Medical School in 1990. Dr. Morganroth is a member of AAD and ASDS.

Dr. Morganroth is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.